Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.574
+0.005 (0.85%)
Nov 21, 2024, 11:52 AM EST - Market open
Bolt Biotherapeutics Employees
Bolt Biotherapeutics had 100 employees as of December 31, 2023. The number of employees increased by 6 or 6.38% compared to the previous year.
Employees
100
Change (1Y)
6
Growth (1Y)
6.38%
Revenue / Employee
$97,790
Profits / Employee
-$650,850
Market Cap
21.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 100 | 6 | 6.38% |
| Dec 31, 2022 | 94 | 3 | 3.30% |
| Dec 31, 2021 | 91 | 26 | 40.00% |
| Dec 31, 2020 | 65 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bionano Genomics | 344 |
| Neuronetics | 203 |
| BioXcel Therapeutics | 74 |
| Enlivex Therapeutics | 71 |
| Inspira Technologies Oxy B.H.N. | 42 |
| Chemomab Therapeutics | 20 |
| NeurAxis | 19 |
| Cocrystal Pharma | 12 |
BOLT News
- 14 days ago - Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting - GlobeNewsWire
- 2 months ago - Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm - Accesswire
- 2 months ago - Bolt Biotherapeutics Announces Changes to its Board of Directors - GlobeNewsWire
- 2 months ago - Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm - Accesswire
- 2 months ago - BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
- 2 months ago - Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions - Accesswire
- 2 months ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt - PRNewsWire
- 2 months ago - Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm - Accesswire